By Christian Cattaruzza
As an early-stage or small-sized biotech company, you need to move fast and be nimble. Success is measured in sustained progress towards milestones. Time is not on your side and you need to get it right the first time.
The key to success is understanding that while the fastest path is often tempting, the right path is to ensure product quality and viability while expediting the development timeline. And sometimes, predicting which path will be most successful for your molecule requires serious strategic thinking and experience in key areas such as
- Financial planning
- Cell line development
- Process development
- Technology selection
- Regulatory and risk assessment
Engaging a proven service provider to help prevent missteps and find the best development pathway, can make your program a success.
In this blog post, we have selected a few key considerations for today’s biopharmaceutical executives: